Clinical trials
Sepsis clinical trials
Below are recruiting sepsis clinical trials, each written for real people, not researchers. We’re tracking 267 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07740304Recruiting
Blood flow test to predict survival in sepsis patients
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
Edirne, MerkezAges 18 years+ - NCT04513288Recruiting
Immunonutrition with L-citrulline for ICU sepsis patients
This trial tests whether adding L-citrulline to tube feeding (enteral nutrition) can improve outcomes for people in the ICU with sepsis or septic shock. It may help support the body’s immune response while you’re critically ill.
Rennes, Brittany RegionAges 18 years+ - NCT07727265Recruiting
Sepsis and blood vessel injury study
This trial is testing a new approach to understand how sepsis (a severe infection) damages blood vessels. It looks at tiny particles released by cells and a protein called PLIN3 to see if they can help protect blood vessels in patients with sepsis.
Nanjing, JiangsuAges 18–80 - NCT07706413Recruiting
Plasma exchange for children with severe sepsis
This trial tests whether removing harmful substances from the blood (plasma exchange) can help children with severe infections that cause organ failure or very low blood pressure. If your child is in the hospital with severe sepsis or septic shock and is between 1 month and 18 years old, this treatment might be an option.
Shibīn al Kawm, Menoufia GovernorateAges 1 month–18 years - NCT07707765Recruiting
Early help after sepsis in the ICU to prevent PTSD
This study tests whether early psychological support after sepsis in the ICU can reduce the chance of developing posttraumatic stress disorder (PTSD). If you recently left the ICU after sepsis, you may be able to join.
AshkelonAges 18–120 - NCT07707622Enrolling by invitation
Sepsis treatment study for ICU patients
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
BeijingAges 18 years+ - NCT07711535Recruiting
Developing Sepsis Quality Indicators for Sub-Saharan Africa
This study aims to develop quality indicators for early sepsis care in Sub-Saharan Africa using a structured expert consensus process (modified Delphi). Healthcare professionals with experience in sepsis care or research in low- and middle-income countries are invited to participate in online survey rounds.
KumasiAges 18 years+ - NCT06655389Recruiting
Link between PLA levels and sepsis heart failure severity
This study looks at how levels of a substance called PLA relate to how severe sepsis-related heart failure is. It may help doctors understand your condition better and guide treatment.
Beijing, Beijing MunicipalityAges 50–90 - NCT06657781Recruiting
Platelet function study in patients with sepsis
This study looks at how platelets (small cells that help blood clot) behave in people with severe infections (sepsis). It explores a specific part of the immune system (inflammasome) linked to platelet activation, which may help develop better treatments for serious infections.
Les Abymes, GuadeloupeAges 18 years+ - NCT07670624Recruiting
Biomarker test for bacterial infection in newborns
This trial tests a new biomarker (T6A) to detect bacterial infections in newborn babies. It aims to help doctors diagnose infections faster and more accurately.
SalzburgAges Any age - NCT06689189Recruiting
Detecting sepsis early with blood fluorescence
This trial uses a blood fluorescence test to check for early signs of sepsis. It may help doctors diagnose sepsis faster, allowing for quicker treatment.
Ningbo, ZhejiangAges 18 years+ - NCT07610486RecruitingPhase 1/Phase 2
Better ampicillin dosing for preterm infants
This study gives preterm babies the standard antibiotic ampicillin and checks the amount in their blood to find the best dose. It may help make sure the medicine works well and is safe for babies born early.
Durham, North CarolinaAges birth–1 week - NCT05836272RecruitingPhase 4
Early norepinephrine for low blood pressure in sepsis
This trial tests whether starting norepinephrine early can improve outcomes for adults with sepsis who have low blood pressure. It may help stabilize circulation sooner and reduce complications from severe infection.
TunisAges 18 years+ - NCT07599644Recruiting
Sepsis Risk Study in Chinese ICU Patients
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
Shaoguan, GuangdongAges 18 years+ - NCT05784740Recruiting
Exercise program to improve recovery after sepsis
This study tests whether a structured, supervised exercise program helps people recover better after sepsis. It may improve physical fitness and day-to-day outcomes over about 12 weeks.
Vancouver, British ColumbiaAges 19 years+ - NCT06745115Recruiting
Using blood fluorescence to detect sepsis
This trial tests a new way to detect sepsis using fluorescence from a blood sample. It may help doctors identify sepsis earlier and improve treatment.
Guangzhou, GuangdongAges 18 years+ - NCT06670963RecruitingPhase 4
Epoetin alfa and iron for anemia in sepsis
This trial tests whether a combination of epoetin alfa (a medicine that boosts red blood cell production) and iron derisomaltose (an iron supplement) can safely treat anemia in people with sepsis or septic shock. It may help improve your energy and recovery.
KatowiceAges 18 years+ - NCT06749483Recruiting
Gut bacteria and infection in intensive care patients
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
Jena, ThuringiaAges 18 years+ - NCT07502794Recruiting
Long-term study of sepsis patients after ICU care
This study follows up with patients who had sepsis in the ICU to understand their long-term health outcomes. It may help improve care for future patients.
Passo Fundo, Rio Grande do SulAges 18 years+ - NCT07454421Enrolling by invitationPhase 1/Phase 2
Racecadotril for organ injury in sepsis patients
This trial tests if Racecadotril, a medication that may protect organs from damage, can help people with sepsis (a severe infection that affects the whole body). It is for patients who are in the hospital and have a certain level of organ injury.
Guanzhou, GuangdongAges 18–80 - NCT07442552Recruiting
Studying sepsis risk after major abdominal surgery
This trial looks at genetic markers to better predict sepsis after major abdominal surgery. It may help find patients at higher risk so they can be treated earlier.
Bucharest, Sector 2Ages 18 years+ - NCT07436130Recruiting
Curcumin for adults with sepsis in the ICU
This trial tests if curcumin (a natural compound found in turmeric) can help critically ill patients fighting sepsis, a life-threatening response to infection. It is for adults who are already receiving food through a feeding tube in the ICU.
Guadalajara, JaliscoAges 18 years+ - NCT07413094RecruitingPhase 2
Testing a new drug for sepsis-related lung injury
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
BeijingAges 18–75 - NCT07407868Recruiting
Call for life: Sepsis study at hospital
This study follows adults hospitalized with sepsis to help improve care. You will be visited daily while in the hospital and get a phone call after you leave.
KampalaAges 18 years+
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for sepsis?
- Yes. Clin2 currently lists 267 recruiting sepsis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a sepsis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a sepsis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.